Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics

Por Gupta, Sachin, Termini, James M., Kanagavelu, Saravana, Stone, Geoffrey W.
Publicado em 2013

Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors

Por Gupta, Sachin, Termini, James M., Issac, Biju, Guirado, Elizabeth, Stone, Geoffrey W.
Publicado no PLoS One (2016)

Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8(+) T Cell Responses and Protection from Viral Challen...

Por Gupta, Sachin, Termini, James M., Raffa, Francesca N., Williams, Cindi-Ann, Kornbluth, Richard S., Stone, Geoffrey W.
Publicado em 2014

EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine

Por Gupta, Sachin, Termini, James M., Niu, Liguo, Kanagavelu, Saravana K., Schmidtmayerova, Helena, Snarsky, Victoria, Kornbluth, Richard S., Stone, Geoffrey W.
Publicado em 2011

A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model

Por Gupta, Sachin, Termini, James M, Rivas, Yaelis, Otero, Miguel, Raffa, Francesca N, Bhat, Vikas, Farooq, Amjad, Stone, Geoffrey W
Publicado no Vaccine (2015)

Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines

Por Gupta, Sachin, Termini, James M, Niu, Liguo, Kanagavelu, Saravana K, Rahmberg, Andrew R, Kornbluth, Richard S, Evans, David T, Stone, Geoffrey W
Publicado em 2011

HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity

Por Kanagavelu, Saravana, Termini, James M., Gupta, Sachin, Raffa, Francesca N., Fuller, Katherine A., Rivas, Yaelis, Philip, Sakhi, Kornbluth, Richard S., Stone, Geoffrey W.
Publicado em 2014

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine

Por Kanagavelu, Saravana K., Snarsky, Victoria, Termini, James M., Gupta, Sachin, Barzee, Suzanne, Wright, Jacqueline A., Khan, Wasif N., Kornbluth, Richard S., Stone, Geoffrey W.
Publicado em 2011

DNA Vaccine Molecular Adjuvants SP-D-BAFF and SP-D-APRIL Enhance Anti-gp120 Immune Response and Increase HIV-1 Neutralizing Antibody Titers

Por Gupta, Sachin, Clark, Emily S., Termini, James M., Boucher, Justin, Kanagavelu, Saravana, LeBranche, Celia C., Abraham, Sakhi, Montefiori, David C., Khan, Wasif N., Stone, Geoffrey W.
Publicado no J Virol (2015)

Preclinical evaluation of HIV-1 therapeutic ex vivo dendritic cell vaccines expressing consensus Gag antigens and conserved Gag epitopes

Por Niu, Liguo, Termini, James M., Kanagavelu, Saravana K., Gupta, Sachin, Rolland, Morgane M., Kulkarni, Viraj, Pavlakis, George N., Felber, Barbara K., Mullins, James I., Fischl, Margaret A., Stone, Geoffrey W.
Publicado em 2011